Electromed (ELMD)
(Delayed Data from AMEX)
$18.65 USD
+0.22 (1.19%)
Updated Aug 7, 2025 03:50 PM ET
After-Market: $18.83 +0.18 (0.97%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth F Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ELMD 18.65 +0.22(1.19%)
Will ELMD be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ELMD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ELMD
Globus Medical (GMED) Beats Q2 Earnings and Revenue Estimates
Here is Why Growth Investors Should Buy Electromed (ELMD) Now
ELMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
InspireMD, Inc. (NSPR) Reports Q1 Loss, Tops Revenue Estimates
Si-Bone (SIBN) Reports Q1 Loss, Tops Revenue Estimates
PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates
Other News for ELMD
Electromed management to meet virtually with B. Riley
Electromed, Inc. to Participate in the Canaccord Genuity 45th Annual Growth Conference | ELMD ...
Electromed (ELMD) Receives Buy Rating from Roth Capital | ELMD Stock News
Electromed (ELMD) Receives Positive Coverage and $29 Target from Roth Capital | ELMD Stock News
Electromed initiated with bullish view at Roth Capital, here's why